Tags

Type your tag names separated by a space and hit enter

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
J Travel Med. 2020 05 18; 27(3)JT

Authors+Show Affiliations

Environmental and Occupational Health Sciences, School of Public Health; Professor of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center, 2020 Gravier Street New Orleans, Louisiana 70112 USA.

Pub Type(s)

Letter

Language

eng

PubMed ID

32186711

Citation

Diaz, James H.. "Hypothesis: Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Increase the Risk of Severe COVID-19." Journal of Travel Medicine, vol. 27, no. 3, 2020.
Diaz JH. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020;27(3).
Diaz, J. H. (2020). Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. Journal of Travel Medicine, 27(3). https://doi.org/10.1093/jtm/taaa041
Diaz JH. Hypothesis: Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Increase the Risk of Severe COVID-19. J Travel Med. 2020 05 18;27(3) PubMed PMID: 32186711.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. A1 - Diaz,James H, PY - 2020/03/10/received PY - 2020/03/14/revised PY - 2020/03/17/accepted PY - 2020/3/19/pubmed PY - 2020/5/27/medline PY - 2020/3/19/entrez JF - Journal of travel medicine JO - J Travel Med VL - 27 IS - 3 SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/32186711/full_citation L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1093/jtm/taaa041 DB - PRIME DP - Unbound Medicine ER -